Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRHI Magnesita Regulatory News (RHIM)

Share Price Information for RHI Magnesita (RHIM)

Share Price is delayed by 15 minutes
Get Live Data
2,730.00    0.00 (0.00%)
Bid:
2,770.00
Ask:
2,805.00
Spread: 35.00 (1.264%)
Market Cap: £1.29b
RHIM Live PriceLast checked at - London Stock Exchange

Intraday RHI Magnesita Share Chart

Director/PDMR Shareholding

28 Mar 2025 16:12

RNS Number : 7644C
RHI Magnesita N.V.
28 March 2025
 

RHI Magnesita N.V.

("RHI Magnesita" or the "Company")

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

RHI Magnesita N.V. announces that on 25 March 2025, a person discharging managerial responsibilities ("PDMR") exercised share options over 58,755 ordinary shares, represented by depositary interests, of €1 each (the "Award") in the capital of the Company ("Ordinary Shares" or "Shares"). The Award, made under the terms of the Company's Long Term Incentive Plan ("LTIP"), was granted on 8 March 2022.

 

The Award vested on 17 March 2025, following the assessment of the performance conditions which are disclosed in the Remuneration Report on page 224 of the 2024 Annual Report, available on the Company's website at www.rhimagnesita.com.

 

Shares acquired on exercise must be retained until the fifth anniversary of the date of grant, being 8 March 2027, other than to pay related taxes. Shares are being sold to cover taxes and this is expected to conclude in the course of the forthcoming week. The Award is subject to clawback provisions as outlined in the LTIP rules, available on the Company's website.

 

To satisfy the exercise of these Awards, Shares are being transferred from the Company's treasury account and being sold in the market to cover taxes. No consideration is payable.

 

The PDMR exercised their Award as follows:

 

Director/PDMR

Position

Options exercised

Shares sold to cover personal tax liabilities

Stefan Borgas

Chief Executive Officer

58,755

9,464

 

The notification below is made in accordance with the requirements of the EU Market Abuse Regulation as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Stefan Borgas

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

RHI Magnesita N.V.

b)

 

LEI

 

724500UWG6A61XNA3Y36

 

National company register number: 68991665

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

RHI Magnesita NV - Ordinary shares

Identification code

Securities no.: 38785413, ISIN no.: NL0012650360

b)

 

Nature of the transaction

 

1. Exercise of an award granted on 8 March 2022 under the RHI Magnesita Long Term Incentive Plan ("LTIP")

2. Sales of shares to fund the tax liability due

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1. Nil

58,755

2. £33.21

2,920

3. £33.13

3,559

4. £32.35

2,985

d)

 

Aggregated information

Aggregated volume

Aggregated Price

1. 58,755

Nil

2. 2,920

£96,973.2

3. 3,559

£ 117,909.67

4. 2,985

£ 96,564.8

- Aggregated volume

 9,464 shares sold

- Price

£311,448

e)

 

Date of the transaction

 

25 March 2025 to 27 March 2025

f)

 

Place of the transaction

 

London Stock Exchange - Main Market

 

 

For further enquiries, please contact:

Chris Bucknall, Head of Investor Relations

Tel: +43 699 1870 6490

Email: chris.bucknall@rhimagnesita.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFLRVIITFIE
Date   Source Headline
16th Feb 20216:12 pmRNSTransaction in Own Shares
15th Feb 20215:42 pmRNSTransaction in Own Shares
12th Feb 20216:18 pmRNSTransaction in Own Shares
11th Feb 20215:59 pmRNSTransaction in Own Shares
10th Feb 20215:30 pmRNSTransaction in Own Shares
9th Feb 20216:21 pmRNSTransaction in Own Shares
8th Feb 20216:08 pmRNSTransaction in Own Shares
5th Feb 20215:28 pmRNSTransaction in Own Shares
4th Feb 20216:17 pmRNSTransaction in Own Shares
3rd Feb 20217:00 amRNSTransaction in Own Shares
1st Feb 20216:28 pmRNSTransaction in Own Shares
29th Jan 20216:22 pmRNSTransaction in Own Shares
28th Jan 20216:05 pmRNSTransaction in Own Shares
27th Jan 20215:53 pmRNSTransaction in Own Shares
26th Jan 20215:35 pmRNSTransaction in Own Shares
25th Jan 20215:26 pmRNSTransaction in Own Shares
22nd Jan 20216:26 pmRNSTransaction in Own Shares
21st Jan 20216:08 pmRNSTransaction in Own Shares
20th Jan 20215:41 pmRNSTransaction in Own Shares
19th Jan 20215:29 pmRNSTransaction in Own Shares
19th Jan 20215:28 pmRNSTransaction in Own Shares
15th Jan 20216:26 pmRNSTransaction in Own Shares
13th Jan 20215:55 pmRNSTransaction in Own Shares
12th Jan 20216:01 pmRNSTransaction in Own Shares
11th Jan 20216:27 pmRNSTransaction in Own Shares
8th Jan 20216:05 pmRNSTransaction in Own Shares
7th Jan 20215:52 pmRNSTransaction in Own Shares
6th Jan 20216:16 pmRNSTransaction in Own Shares
5th Jan 20216:07 pmRNSTransaction in Own Shares
5th Jan 20217:00 amRNSTransaction in Own Shares
4th Jan 20214:18 pmRNSTotal Voting Rights
22nd Dec 20206:24 pmRNSTransaction in Own Shares
21st Dec 20205:53 pmRNSTransaction in Own Shares
18th Dec 20206:14 pmRNSTransaction in Own Shares
17th Dec 20206:02 pmRNSTransaction in Own Shares
16th Dec 20206:23 pmRNSTransaction in Own Shares
16th Dec 20207:00 amRNSTransaction in Own Shares
22nd Oct 20207:00 amRNSTrading Statement
1st Sep 20207:15 amRNSHolding(s) in Company
7th Aug 202011:40 amRNSDirector/PDMR Shareholding
5th Aug 20207:00 amRNSHalf-year Report
28th Jul 20209:41 amRNSDirectorate Change
1st Jul 20207:00 amRNSTrading Statement
18th Jun 20204:38 pmRNSResult of AGM
27th May 20207:15 amRNSExternal Directorship
20th May 202010:51 amRNS2020 Annual Bonus metrics
6th May 20205:00 pmRNSHolding(s) in Company
6th May 20204:31 pmRNSNotice of AGM
5th May 20207:00 amRNSQ1 2020 Trading Update
15th Apr 20205:55 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.